Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Sep. 30, 2024

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	September 30, 2024		December 31, 2023
Compensation, bonuses and related benefits	$	3,432	$	3,496
Research and development	6,483		4,895
Accrued severance, bonus, and retention (1)	—		2,476
Accrued offering costs in connection with pre-closing financing	—		3,334
Accrued transaction costs related to reverse merger	—		2,557
Other	523		737
Total accrued expenses and other current liabilities	$	10,438	$	17,495

(1) Includes accrued severance, bonus, and retention payments for former Neoleukin employees.